These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Insights into the role of Toll-like receptors in modulation of T cell responses. Kulkarni R; Behboudi S; Sharif S Cell Tissue Res; 2011 Jan; 343(1):141-52. PubMed ID: 20680345 [TBL] [Abstract][Full Text] [Related]
49. Innate immunity and toll-like receptor antagonists: a potential role in the treatment of cardiovascular diseases. Lin E; Freedman JE; Beaulieu LM Cardiovasc Ther; 2009; 27(2):117-23. PubMed ID: 19426249 [TBL] [Abstract][Full Text] [Related]
51. [Innate immunity: structure and function of TLRs]. Delneste Y; Beauvillain C; Jeannin P Med Sci (Paris); 2007 Jan; 23(1):67-73. PubMed ID: 17212934 [TBL] [Abstract][Full Text] [Related]
52. Recent progress in the development of Toll-like receptor (TLR) antagonists. Patra MC; Choi S Expert Opin Ther Pat; 2016 Jun; 26(6):719-30. PubMed ID: 27136061 [TBL] [Abstract][Full Text] [Related]
53. TLR Agonists as Adjuvants for Cancer Vaccines. Li JK; Balic JJ; Yu L; Jenkins B Adv Exp Med Biol; 2017; 1024():195-212. PubMed ID: 28921471 [TBL] [Abstract][Full Text] [Related]
55. Importance of Nucleic Acid Recognition in Inflammation and Autoimmunity. Barrat FJ; Elkon KB; Fitzgerald KA Annu Rev Med; 2016; 67():323-36. PubMed ID: 26526766 [TBL] [Abstract][Full Text] [Related]
56. A new era of targeting the ancient gatekeepers of the immune system: toll-like agonists in the treatment of allergic rhinitis and asthma. Aryan Z; Holgate ST; Radzioch D; Rezaei N Int Arch Allergy Immunol; 2014; 164(1):46-63. PubMed ID: 24853609 [TBL] [Abstract][Full Text] [Related]
57. Toll-like receptors in systemic lupus erythematosus: potential targets for therapeutic intervention. Horton CG; Farris AD Curr Allergy Asthma Rep; 2012 Feb; 12(1):1-7. PubMed ID: 22086298 [TBL] [Abstract][Full Text] [Related]
58. Melatonin, a toll-like receptor inhibitor: Current status and future perspectives. Tamtaji OR; Mobini M; Reiter RJ; Azami A; Gholami MS; Asemi Z J Cell Physiol; 2019 Jun; 234(6):7788-7795. PubMed ID: 30387141 [TBL] [Abstract][Full Text] [Related]
59. Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists. Federico S; Pozzetti L; Papa A; Carullo G; Gemma S; Butini S; Campiani G; Relitti N J Med Chem; 2020 Nov; 63(22):13466-13513. PubMed ID: 32845153 [TBL] [Abstract][Full Text] [Related]